Phase 2 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with ulcerative colitis (a condition causing inflammation in the large intestine)
- People whose ulcerative colitis is currently in a mild to moderate active stage, measured by a scoring system called the Mayo score, with a score between 3 and 8
- People whose symptoms match a pattern described in Traditional Chinese Medicine (TCM) as "damp-heat syndrome of the large intestine" — this includes main symptoms such as diarrhea, bloody or mucus-containing stools, abdominal pain, and a feeling of needing to pass stools even when the bowel is empty, along with some additional symptoms such as a burning sensation around the back passage, mild fever, dry or bitter mouth, and dark-coloured urine (confirm with trial site for full assessment)
- People who are able to tolerate taking a traditional Chinese herbal medicine called Baitouweng Decoction
- People who are able to undergo a colonoscopy (a camera examination of the bowel) and a procedure called TET (confirm with trial site for details on this procedure)
- People who have been fully informed about the trial and have agreed to take part
Who may not be able to join:
- People who have other conditions that could also cause diarrhea, such as infectious colitis, radiation enteritis, or Crohn's disease
- People who have serious conditions affecting the heart, brain, lungs, liver, or kidneys
- People who are unlikely to be able to follow through with all steps of the trial process
- People considered unsuitable for other reasons, as determined by the trial team (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Faming Zhang, PhD, The Second Hospital of Nanjing Medical University
Phone: 02558509670
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The concentration of fecal calprotecin.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.